Results 221 to 230 of about 3,030,865 (307)
SphB1 export system for antigen presentation to the respiratory tract by a live pertussis vaccine. [PDF]
Santiesteban-Lores LE +7 more
europepmc +1 more source
This study reveals that NF‐κB1‐driven TRAIP upregulation in ALD correlates with disease severity. Mechanistically, TRAIP directly binds β‐catenin via its CC domain and promotes its K48‐linked ubiquitination and degradation, which is independent of the GSK3β/β‐TrCP pathway.
Zhan Wu +13 more
wiley +1 more source
M13 phage-based antigen presentation and immune response activation in vaccine development for animal infectious diseases. [PDF]
Zhou G, Zhang J, Zhang Z, Cao S, Li Y.
europepmc +1 more source
Prostate cancer is immunologically ‘cold’, with scarce, dysfunctional type 1 conventional dendritic cells (cDC1s) that limit T cell priming. We introduce an aptamer‐targeted liposomedelivering FMS‐like tyrosine kinase 3 ligand (Flt3L) and chlorin e6 (Ce6). Ultrasound induces antigen release and cDC1s recruitment, creating an in situ cDC1 vaccine.
Jiayi Wang +8 more
wiley +1 more source
Sorting nexin 5 deficiency impairs MHC class II antigen presentation and inflammatory responses during tuberculosis. [PDF]
Dias BRS +6 more
europepmc +1 more source
ABSTRACT Autism Spectrum Disorder (ASD) is associated with gut microbiota dysbiosis, yet the contribution of specific microbial metabolic pathways remains unclear. Reanalysis of a public ASD cohort revealed reduced functional potential in microbial tryptophan oxidative metabolism.
Rui Guo +14 more
wiley +1 more source
PICALM regulates a human microglial antigen presentation program in Alzheimer’s disease
De Strooper B +23 more
europepmc +1 more source
Cancer Immune Responsiveness and MHC Class I Antigen Presentation: Mechanisms of Immune Escape and Immunotherapy Resistance in Gastrointestinal Cancers. [PDF]
Grizzi F +13 more
europepmc +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source

